Get started
Author

Lexy Adams

Observed institution: Brooke Army Medical Center
OpenAlex ID: A5074290375
300 Final analysis of a prospective, randomized, double-blind, placebo-controlled phase IIb trial of tumor lysate, particle-loaded, dendritic cell vaccine in stage III/IV melanoma: 36-month analysis
2020 · Lexy Adams, Robert Chick, et al. · Regular and Young Investigator Award Abstracts · 2
PDF
310 The effect of pretreatment with G-CSF prior to dendritic cell collection during the phase IIb trial of an autologous DC-based vaccine for advanced, resectable melanoma
2020 · Anne O’Shea, Robert Chick, et al. · Regular and Young Investigator Award Abstracts · 2
PDF
542 Randomized trial of tumor lysate particle only vaccine vs. tumor lysate particle-loaded, dendritic cell vaccine to prevent recurrence of resected stage III/IV melanoma: 36-month analysis
2021 · Elizabth Carpenter, Lexy Adams, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
431 Prospective, randomized trial of the tumor lysate, particle only vaccine compared to the tumor lysate, particle-loaded, dendritic cell vaccine to prevent recurrence for resected stage III/IV melanoma
2020 · Patrick McCarthy, Lexy Adams, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Works count: 4
Citation count: 6
H-index: 2
I10-index:
Year
Topic
Type